31/10/2025
It was great to hear from one of our Noctura 400 users, and Dedoc Diabetes Online Community voice Mark Tiller recently. Mark let us film his diabetes and Noctura 400 journey, from his diagnosis in 1996 to the present day, as a much healthier, happy man. We're thrilled that he is now on such a positive path to better health, and that Noctura 400 has played such a key part in it.
Amazed with his Noctura 400 results, Ophthalmologists were able to release Mark back into the general diabetic eye screening programme, he also needed new glasses, and an added benefit due to the great improvement in is his eye health, was that Mark also became eligible for Mounjaro treatment, a GLP-1 drug from Eli Lilly and Company, that is generally not given to those with diabetic retinopathy, because it can worsen the condition.